Staci Dunn
Family · Knoxville, TNNPI 1194289835
Payments from drug & device makers
Across 454 payments — averaging $16.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$824
- Boston Scientific$716
- Impel Pharmaceuticals Inc.$578
- Collegium Pharmaceutical, Inc.$570
- Biohaven Pharmaceutical Holding Company Ltd.$456
- plus $3K from 22 others
What the payments were for
- Food & beverage$7,24699%
- Education$501%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 73 | $1,329 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 63 | $824 |
| Boston Scientific | 23 | $716 |
| Impel Pharmaceuticals Inc. | 56 | $578 |
| Collegium Pharmaceutical, Inc. | 48 | $570 |
| Biohaven Pharmaceutical Holding Company Ltd. | 22 | $456 |
| Pfizer | 24 | $394 |
| Medtronic | 22 | $326 |
| Lilly USA, LLC | 18 | $294 |
| Amgen | 16 | $249 |
| Scilex Pharmaceuticals Inc. | 16 | $241 |
| Arbor Pharmaceuticals, Inc. | 15 | $197 |
| Nevro Corp. | 6 | $192 |
| Hikma Pharmaceuticals USA | 8 | $142 |
| Fidia Pharma USA Inc. | 6 | $125 |
| IBSA Pharma Inc. | 6 | $95 |
| Curonix LLC | 3 | $89 |
| Biodelivery Sciences International, Inc. | 5 | $87 |
| Lundbeck LLC | 5 | $78 |
| Azurity Pharmaceuticals, Inc. | 4 | $69 |
| Biohaven Pharmaceuticals, Inc. | 4 | $58 |
| Abbott | 3 | $53 |
| GRT US Holding, Inc. | 2 | $37 |
| Redhill Biopharma Inc. | 2 | $26 |
| Painteq LLC | 1 | $22 |
| Orthogenrx Inc. | 1 | $18 |
| Amneal Pharmaceuticals LLC | 1 | $16 |
| Almatica Pharma LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Omnia$131
- WaveWriter Alpha Prime 16$123
- BOTOX$118
How this compares
$7,295 in reported general payments places this provider in the 95th percentile of 6,706 family providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 110 | $49,664 |
| UbrelvyUbrogepant | 18 | $27,149 |
| OxycontinOxycodone Hcl | 57 | $24,102 |
| QuliptaAtogepant | 17 | $17,860 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 551 | $13,655 |
| ZtlidoLidocaine | 19 | $12,445 |
| Aimovig AutoinjectorErenumab-Aooe | 12 | $11,639 |
| BelbucaBuprenorphine Hcl | 13 | $10,429 |
| Hysingla ErHydrocodone Bitartrate | 15 | $7,063 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 277 | $6,230 |
| Lidocaine | 49 | $5,941 |
| SymproicNaldemedine Tosylate | 12 | $5,536 |
| Fentanyl | 37 | $5,532 |
| Oxycodone Hcl | 267 | $5,035 |
| MovantikNaloxegol Oxalate | 12 | $4,758 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca | $570 | $60,093123 claims |
| AbbVieUbrelvy, Qulipta | $1,329 | $45,00835 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $241 | $12,44519 claims |
| Redhill Biopharma Inc.Movantik | $26 | $4,75812 claims |
| Hikma Pharmaceuticals USABuprenorphine, Morphine Sulfate | $142 | $4,55340 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,706 family providers in Tennessee.
Other family in Knoxville
- Dana WebberKnoxville$499K
- Tiffany SipeKnoxville$87K
- Ashley BonnellKnoxville$49K
- Stacey MaltmanKnoxville$34K
- Katherine JohnsonKnoxville$32K
- Ashley BellKnoxville$22K
- Carol HawkinsKnoxville$22K
- Mina FarrarKnoxville$21K
- Amy AllenKnoxville$21K
- Sarah HarderKnoxville$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.